SciTransfer
Organization

CLEARDETECTIONS B.V.

Wageningen-based specialist in validating plant health diagnostic tests, validated protocols, and NGS-based pest detection for European laboratories.

Technology SMEfoodNLNo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€68K
Unique partners
46
What they do

Their core work

CLEARDETECTIONS B.V. is a Dutch private company based in Wageningen — Europe's foremost agricultural research hub — specializing in the development and validation of laboratory diagnostic tests for detecting plant pests and pathogens. Their core work involves designing test performance studies, establishing validated protocols, and producing reference materials that enable official plant health laboratories across Europe to reliably identify harmful organisms. They bring molecular diagnostic expertise, including next-generation sequencing (NGS), to large pan-European consortia working on plant health protection. They also provide proficiency testing services and training to standardize diagnostic quality across national laboratories.

Core expertise

What they specialise in

Plant pathogen diagnostic test validationprimary
1 project

VALITEST (2018–2021) was entirely focused on validating diagnostic tests for plant health, and all of the organization's H2020 keywords — validated protocols, test performance study, proficiency — come from this project.

Next-generation sequencing for pest identificationprimary
1 project

VALITEST keywords explicitly include 'next generation sequencing' alongside detection, identification, and diagnostic, pointing to NGS as a core methodological competency.

Reference materials and proficiency testingsecondary
1 project

Keywords 'reference material' and 'proficiency' from VALITEST indicate they support inter-laboratory quality assurance programs, a specialized service within plant health diagnostics.

Laboratory training and protocol disseminationsecondary
1 project

'Training' appears in the VALITEST keyword set, suggesting they also deliver capacity-building activities to diagnostic laboratories adopting new validated methods.

Soil and crop health support servicesemerging
1 project

Their third-party role in SOILCARE (2016–2021), a project on profitable and sustainable crop production, suggests peripheral involvement in broader agricultural ecosystem health, though with no keyword evidence of a deep contribution.

Evolution & trajectory

How they've shifted over time

Early focus
Crop production support services
Recent focus
Plant health diagnostic validation

CLEARDETECTIONS entered the H2020 programme first via SOILCARE (2016) as a third party with no attributed keywords, indicating a subcontracting or service-provider role at the edges of a large agronomy consortium. By 2018, their participation in VALITEST shows a sharply defined identity — every project keyword maps directly to plant health diagnostics, molecular detection, and laboratory validation. There is no broad thematic evolution here; rather, the data reveals a company that started at the margins of agricultural research and then secured a more substantive, funded role squarely within their diagnostic niche.

CLEARDETECTIONS is moving toward a more central, funded role in standardized plant health diagnostics, and their NGS expertise positions them well for future EU initiatives around phytosanitary surveillance and early pest detection.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European19 countries collaborated

CLEARDETECTIONS has never coordinated an H2020 project — they consistently join as a participant or third party, positioning themselves as a specialist service provider within larger consortia. Their 46 unique consortium partners across 19 countries from just two projects reflects involvement in large, pan-European networks typical of EUPHRESCO or EPPO-linked plant health programs. This profile suggests they are reliable, well-networked contributors who bring narrow but highly credible technical depth to consortia that need validated diagnostic capability.

Despite only two H2020 projects, CLEARDETECTIONS has worked with 46 distinct consortium partners across 19 countries — a footprint that reflects participation in large, multi-partner European plant health networks rather than bilateral or regional collaborations. Their Wageningen base places them within immediate reach of WUR, NPPO-NL, and a dense cluster of plant science organizations.

Why partner with them

What sets them apart

CLEARDETECTIONS occupies a specific and defensible niche: the technical validation of diagnostic tests for plant health, rather than diagnostics as a clinical or commercial service. This type of expertise — writing test performance studies, producing reference materials, running proficiency schemes — is essential infrastructure for official plant health laboratories but is rarely the visible face of large consortia. Their Wageningen location and NGS capability make them a credible and well-connected specialist for any EU project that needs its diagnostic outputs to meet EPPO or ISPM standards.

Notable projects

Highlights from their portfolio

  • VALITEST
    Their only directly funded H2020 project and the clearest expression of their core competency — validating plant health diagnostics using NGS and producing reference materials and validated protocols for European laboratories.
  • SOILCARE
    A large, multi-partner RIA on sustainable crop production where CLEARDETECTIONS served as a third party, demonstrating their embeddedness in Wageningen's broader agricultural research ecosystem beyond pure diagnostics.
Cross-sector capabilities
Environmental monitoring — molecular detection methods applicable to soil and water pathogen surveillanceAgricultural biotechnology — NGS-based species identification transferable to biodiversity and biosecurity contextsLaboratory accreditation and quality assurance — test validation expertise relevant to any regulated testing domain
Analysis note: Profile is based on only two H2020 projects, one of which is a third-party role with no keyword attribution. The keyword set from VALITEST is specific and coherent, enabling a reasonably reliable characterization of their diagnostic niche, but the absence of coordinator roles, limited funding volume (EUR 67,998 total), and short active window (2016–2018 start dates) leave significant uncertainty about company size, current activity level, and post-H2020 trajectory.